Viewing Protocol Section

Viewing Protocol Section

Thank You for evaluating our software.

Clinical Trials

To give you an idea of how we make custom software. We have taken all of the Clinical Trials Information from our Federal Government(https://clinicaltrials.gov/).

The JSON File Structure of the files is as follows: Full Study -> Study => Sections => Modules. You are currently viewing a Protocol Section and its Modules.

We give the table structure here to give you an idea of what you are looking at. We put the explanation to the left and the data to the right.

A Protocol Section has the following Modules.

1. Identification Module

2. Status Module

3. Sponsor Collaborators Module

4. Oversight Module

5. Description Module

6. Conditions Module

7. Design Module

8. Arms Interventions Module

9. Outcomes Module

10. Eligibility Module

11. Contacts Locations Module

12. References Module

13. IPD Sharing Statement Module

Viewing Protocol Section


Ignite Creation Date: 2024-05-05 @ 11:34 AM
Last Modification Date: 2024-10-26 @ 9:10 AM
Study NCT ID: NCT00088855
Protocol Section: NCT00088855
Start Identification Module Data
Brief Title: Bortezomib and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Previously Untreated Symptomatic Multiple Myeloma
Official Title: Phase II Study of Bortezomib PS-341 and Pegylated Liposomal Doxorubicin as Initial Therapy for Adult Patients With Symptomatic Multiple Myeloma
Acronym: None
Organization: National Cancer Institute NCI
Organization Class: NIH
Organization Study ID: NCI-2014-01607
Secondary IDs
Secondary ID Type Domain Link
NCI-2014-01607 REGISTRY None None
NCI-2012-02810 None None None
CDR377483 None None None
CALGB 10301 OTHER None None
CALGB-10301 OTHER None None
U10CA180821 NIH None None
U10CA031946 NIH CTEP httpsreporternihgovquickSearchU10CA031946
Start Status Module Data
Status Verified Date: 2019-09
Overall Status: COMPLETED
Study First Submit Date:
Study First Submit QC Date:
Last Update Submit Date:
Status:
Start Sponsor Collaborators Module Data
Investigator:
Lead Sponsor: National Cancer Institute NCI
Lead Sponsor Class: NIH
Lead Sponsor: National Cancer Institute NCI
Start Oversight Module Data
Description Module:
Study Last Update Post Date Type(Status Module):
Attachment: Upload